The North America Coronary Stent Market size is predicted to be worth USD 4.41 billion by 2027 from USD 3.10 billion in 2022, growing at a CAGR of 7.30% during the forecast period.
Increasing usage of these coronary stents in the healthcare sector is one factor boosting the market over the period. Growing older people population and lack of awareness about the heart-related stents is propelling the growth. In addition, unhealthy lifestyle changes like the intake of alcohol and smoking, the launch of new creative products that assist the companies in gaining profits surge the market demand.
Favorable reimbursement policies from government and other private organizations and having sound knowledge about the related heart stent increase and drive market growth. Growing demand for catheters, stents, and balloons accelerates the growth.
The cost associated with the treatment is so expensive, unaffordable for ordinary people, hampering the market growth. Lack of awareness among the patients for early diagnosis of the treatment, the shortage of expert professionals in the cardiology field for the treatment, strict regulations for the approval of products, and their launch are also impeding the market. In addition, alternative methods during the treatment of coronary stent disorders are limiting growth. Failure of the device products and also the cancellation of the outcomes of the coronary stent market may also restrict the growth.
This research report on North American has been segmented & sub-segmented into the following categories:
By Mode of Delivery:
Regionally, the North American region has occupied a significant share of the market in the global 2019. The North American region accounts for the largest share and dominates the coronary stent market during the period. The growth of this region is attributed to factors such as advanced technologies by the key players coming up with the new devices into the market. Growing focus on inventing new device launches is propelling the market growth of this region.
The United States coronary stent market is leading the coronary stent market with the largest share of this region. The growth is due to minimally invasive surgeries and increasing the geriatric population, accelerating the coronary stent market growth during the review period. Also, a considerable number of key players focusing on producing stents and growing awareness related to the risk factors for coronary heart diseases is enhancing the market.
Canadian coronary stent market is expected to witness the highest growth with the highest CAGR of the coronary stent market over the analysis period. It owes to the growing demand for these procedures due to advantages like less pain, reduces scarring, and some factors that fuel the market. In addition, Canada is estimated to have a quick growth rate due to factors such as growing stipulations for medical devices with expansion in the coronary stent devices market.
KEY MARKET PLAYERS:
A few of the promising companies operating in the North American coronary stents market profiled in this report are Medtronic plc, Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts, and Translumina GmbH.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com